Description
Mechanism of Action:
✔ Acts on uterine smooth muscle – Induces rhythmic contractions to prevent excessive bleeding.
✔ Vasoconstriction effect – Helps reduce blood loss by narrowing blood vessels.
✔ Dopaminergic activity – Can cause mild central nervous system effects.
Indications:
✔ Postpartum Hemorrhage (PPH) Prevention & Treatment
✔ Uterine Atony (Failure of the uterus to contract after delivery)
✔ Facilitation of Placental Expulsion
Key Benefits:
✅ Rapid action in controlling postpartum bleeding
✅ Prevents and manages uterine atony
✅ Reduces risk of postpartum complications
✅ Safe & effective oxytocic agent
Dosage & Administration:
- Standard Dose: 0.2–0.5 mg orally, 3–4 times daily for up to one week post-delivery.
• Route of Administration: Oral
• Food Intake: Can be taken with or without food.
Precautions & Warnings:
- Not recommended for patients with hypertension, eclampsia, or preeclampsia.
• Contraindicated in pregnancy (except during delivery) due to uterine stimulation.
• May cause increased blood pressure – Monitor cardiovascular health.
• Use with caution in patients with liver or kidney impairment.
Possible Side Effects:
- Nausea & Vomiting
• Headache & Dizziness
• Hypertension or Bradycardia
• Abdominal pain due to strong uterine contractions
Storage & Packaging:
- Store below 30°C in a dry place, away from direct sunlight.
• Available in blister packs & bulk packaging as per client needs.
Manufacturing & Regulatory Compliance:
Manufactured by Aetos Life Care in WHO-GMP-certified facilities, adhering to EU-GMP standards for global quality compliance.
Global Export & Supply:
Aetos Life Care exports Ergometrine 0.5 mg Tablets BP to Latin America, Africa, Asia, Europe, and CIS countries, ensuring high-quality and cost-effective pharmaceutical solutions worldwide.
